Characterizing amyloid and tau PET‐based biological stages along the clinical continuum in NACC participants
Together, these findings underscore heterogeneity in amyloid and tau PET burden along the clinical continuum and highlight the application of amyloid and tau PET-based staging frameworks in a clinically heterogeneous sample.
Authors
- Randall S. Johnson (ORCID: https://orcid.org/0000-0002-4084-6639)
- Timothy J. Hohman (ORCID: https://orcid.org/0000-0002-3377-7014)
- Kyan Younes (ORCID: https://orcid.org/0000-0002-9912-1616)
- Derek B. Archer (ORCID: https://orcid.org/0000-0001-8638-0785)
- Logan C. Dumitrescu (ORCID: https://orcid.org/0000-0002-9782-9944)
- Karly Alex Cody (ORCID: https://orcid.org/0000-0001-5996-2560)
- Joseph R. Winer (ORCID: https://orcid.org/0000-0003-4069-3158)
- Duygu Tosun (ORCID: https://orcid.org/0000-0001-5174-3910)
- Elizabeth C. Mormino (ORCID: https://orcid.org/0000-0002-4542-6537)
- Theresa M. Harrison (ORCID: https://orcid.org/0000-0002-2036-3496)
- Christina B. Young (ORCID: https://orcid.org/0000-0001-9535-2137)
- Alaina Durant
- Andrzej Sokołowski (ORCID: https://orcid.org/0000-0002-2787-6665)
Institutions
- University of Wisconsin–Madison (US)
- University of California, San Francisco (US)
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
- University of California, Berkeley (US)
- Stanford University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_104202
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00